Skip to main content

Proceeding contribution from Lord Lansley (Conservative) in the House of Commons on Wednesday, 11 January 2012. It occurred during Ministerial statement on Breast Implants.


Breast Implants

The hon. Gentleman says that this body is entirely funded by the industry. It is true that in relation to pharmaceuticals the MHRA is funded by levies on the pharmaceutical industry, but much of the cost of the regulation of medical devices is actually met by the taxpayer. I regard the MHRA as operating in an independent fashion and its expert and scientific advice as independent from Ministers. None the less, as he says, the review that Earl Howe will lead will examine the lessons to be learned, including those about the effectiveness of regulatory surveillance and enforcement in this country, albeit that the regulatory failure occurred, in essence, in Germany, in the first instance, and in France.


Secondary information

Type
Proceeding contribution
Reference
538 c196 
Session
2010-12
Chamber / Committee
House of Commons chamber
Subjects
Costs Health hazards NHS Plastic surgery Private patients Standards Safety Silicone Breasts
Link
View this Proceeding contribution on www.publications.parliament.uk